Some studies have shown that urinary MCP-1 levels can be used to diagnose, assess the prognosis and treatment response of various inflammatory and non-inflammatory kidney diseases such as: IgA nephropathy, diabetic nephropathy, or polycystic kidney disease [145]. The gene discussed is CCL2; the disease is IgA glomerulonephritis.